Teligent Revenue 2010-2021 | TLGT
Teligent revenue from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Teligent Annual Revenue (Millions of US $) |
2020 |
$45 |
2019 |
$66 |
2018 |
$66 |
2017 |
$60 |
2016 |
$63 |
2015 |
$44 |
2014 |
$34 |
2013 |
$18 |
2012 |
$9 |
2011 |
$8 |
2010 |
$6 |
2009 |
$4 |
Teligent Quarterly Revenue (Millions of US $) |
2021-06-30 |
$10 |
2021-03-31 |
$12 |
2020-12-31 |
$10 |
2020-09-30 |
$14 |
2020-06-30 |
$14 |
2020-03-31 |
$7 |
2019-12-31 |
$16 |
2019-09-30 |
$18 |
2019-06-30 |
$18 |
2019-03-31 |
$13 |
2018-12-31 |
$17 |
2018-09-30 |
$18 |
2018-06-30 |
$16 |
2018-03-31 |
$15 |
2017-12-31 |
$11 |
2017-09-30 |
$11 |
2017-06-30 |
$18 |
2017-03-31 |
$20 |
2016-12-31 |
$14 |
2016-09-30 |
$16 |
2016-06-30 |
$17 |
2016-03-31 |
$16 |
2015-12-31 |
$13 |
2015-09-30 |
$12 |
2015-06-30 |
$9 |
2015-03-31 |
$11 |
2014-12-31 |
$14 |
2014-09-30 |
$7 |
2014-06-30 |
$6 |
2014-03-31 |
$7 |
2013-12-31 |
$7 |
2013-09-30 |
$4 |
2013-06-30 |
$4 |
2013-03-31 |
$4 |
2012-12-31 |
$2 |
2012-09-30 |
$2 |
2012-06-30 |
$2 |
2012-03-31 |
$2 |
2011-12-31 |
$2 |
2011-09-30 |
$2 |
2011-06-30 |
$2 |
2011-03-31 |
$2 |
2010-12-31 |
$2 |
2010-09-30 |
$2 |
2010-06-30 |
$2 |
2010-03-31 |
$1 |
2009-12-31 |
$1 |
2009-09-30 |
$1 |
2009-06-30 |
$1 |
2009-03-31 |
$1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|